ISSN: 1340-6868

Journal Home

Journal Guideline

Breast Cancer Q1 Unclaimed

Springer Japan Japan

Unfortunately this journal has not been claimed yet. For this reason, some information may be unavailable.

Breast Cancer is a journal indexed in SJR in Medicine (miscellaneous) and Oncology with an H index of 66. It has a price of 2690 €. It has an SJR impact factor of 1,054 and it has a best quartile of Q1. It is published in English. It has an SJR impact factor of 1,054.

Type: Journal

Type of Copyright:

Languages: English

Open Access Policy: Open Choice

Type of publications:

Publication frecuency: -

Categories: Medicine (miscellaneous) (Q1) Pharmacology (medical) (Q1) Radiology, Nuclear Medicine and Imaging (Q1) Oncology (Q2)

Price

2690 €

Inmediate OA

NPD

Embargoed OA

0 €

Non OA

Metrics

1,054

SJR Impact factor

66

H Index

105

Total Docs (Last Year)

381

Total Docs (3 years)

3752

Total Refs

1338

Total Cites (3 years)

373

Citable Docs (3 years)

3.29

Cites/Doc (2 years)

35.73

Ref/Doc

Comments

No comments ... Be the first to comment!

Publication speed *

Review quality *

Edition and editorial team *

Institutional email or ORCID *

* The email or ORCID field is only to validate the authenticity of the comment, the identity will not be public. .

Other journals with similar parameters

Nature Biomedical Engineering Q1
Journal of Thoracic Oncology Q1
Annual Review of Clinical Psychology Q1
Lancet Digital Health, The Q1
Journal of Experimental Medicine Q1

Compare this journals

Aims and Scope

Best articles by citations

Flap adhesion and effect on postoperative complication rates using Tissuglu¬Æ in mastectomy patients

Intracystic invasive papillary carcinoma of the male breast with analyses of loss of heterozygosity on chromosome 16q

A proposal for the histopathological diagnosis of ductal carcinoma in situ of the Breast

Long-term prognoses and outcomes of axillary lymph node recurrence in 2,578 sentinel lymph node-negative patients for whom axillary lymph node dissection was omitted: results from one Japanese hospital

Erratum

Immunocytochemical results for HER2 and Ki67 in breast cancer touch-smear cell specimens are reliable

The Japanese Breast Cancer Society clinical practice guideline for epidemiology and prevention of breast cancer

The Japanese Breast Cancer Society clinical practice guidelines for epidemiology and prevention of breast cancer, 2015 edition

A case of cytokeratin 20-positive large-cell neuroendocrine carcinoma of the breast

Results of questionnaires concerning breast cancer surgery in Japan 1980-2003

The incidence and risk factors of related lymphedema for breast cancer survivors post-operation: a 2-year follow-up prospective cohort study

Autologous tissue breast reconstruction following the application of tissue expander

SHOW MORE ARTICLES

Preoperative therapy: recent findings

A non-invasive form of lipid-secreting carcinoma of the breast

The value of primary tumor 18F-FDG uptake on preoperative PET/CT for predicting intratumoral lymphatic invasion and axillary nodal metastasis

From standardization to personalization in breast cancer treatment

Effect of the normal mammary differentiation regulator ELF5 upon clinical outcomes of triple negative breast cancers patients

State of the art of minimally invasive breast biopsy: Principles and practice

Body mass index and gamma-glutamyl transferase expression in normal and cancerous breast tissue

A case report of pigmented mammary Paget's disease mimicking nevus of the nipple

Preoperatively diagnosed ductal carcinoma in situ: risk prediction of invasion and effects on axillary management

Histogram analysis of quantitative pharmacokinetic parameters on DCE-MRI: correlations with prognostic factors and molecular subtypes in breast cancer

Perspective for the development of companion diagnostics and regulatory landscape to encourage personalized medicine in Japan

Surgery for ductal carcinoma in Situ